Zenimaru Yasuo, Harada Norio
Department of Endocrinology and Metabolism, School of Medical Sciences, University of Fukui, Fukui, Japan.
J Diabetes Investig. 2024 Dec;15(12):1725-1726. doi: 10.1111/jdi.14305. Epub 2024 Sep 30.
There are several physiological and pharmacological actions of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide for the regulation of blood glucose and bodyweight.
胰高血糖素样肽-1以及葡萄糖依赖性促胰岛素多肽/胃抑制多肽具有多种生理和药理作用,可调节血糖和体重。